Natera Inc (NASDAQ:NTRA) - Share price


Stock Report

Natera Inc NTRA

Last Price
$126.36

Day Change
5.99|4.98%

As of 17/09/2021
19:58:38 EDT | USD
Minimum 15 Minutes Delay.

Last Close120.37
Day Range119.80 - 126.52
Mkt Cap11.85Bil
52-Wk Range58.65 - 127.19
Yield %-
ISINUS6323071042
Volume1,222,549
P/E-
P/S21.37
P/CF-42.83

Share Price

Financials
201820192020
More ...
Income Statement
Revenue257.65302.33391.01
Operating Income-114.63-130.68-216.28
Net Income-128.15-124.83-229.74
Basic EPS-2.22-1.79-2.84
Avg. Diluted Shares Outstanding587081
Balance Sheet
Current Assets240.52523.17862.66
Non Current Assets27.6559.4969.49
Total Assets268.17582.66932.15
Current Liabilities113.98179.87199.05
Total Liabilities236.01303.95445.92
Total Equity32.16278.71486.24
Cash Flow
Operating Cash Flow-70.58-63.44-182.51
Capital Expenditure-3.88-4.97-19.60
Free Cash Flow-74.46-68.41-202.12

In millions, except "Basic EPS". Currency is USD.

Company Profile

Natera Inc is operative in the healthcare field in the United States. Its core business is to offer invasive and other means of diagnosing the genetic features of a fetus. Natera's array of diagnostic services include Panorama Non-Invasive Prenatal Test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, Anora Products of Conception (POC) test to analyze fetal chromosomes to understand the cause of miscarriage, and Non-Invasive Paternity Testing (PAT), to determine paternity by studying the fragments of fetal deoxyribonucleic acid (DNA) in a pregnant mother's blood and a blood sample from the alleged father. The Company acquires its revenue by billing an insurance carrier, a clinic, or a patient for the test upon delivery of the test result.

Sector

Healthcare

Industry

Diagnostics & Research

Stock Style

Mid-Growth

Fiscal Year Ends

December

Employees

1,815
Key Stats
More ...
Price/Earning TTM-32.62
Price/Book37.74
Price/Sales TTM20.35
Rev Growth (3 year avg)22.84
EPS Growth (3 year avg)-
Operating Margin % TTM-55.31
Net Margin % TTM-58.76
ROE TTM-60.07
Debt/Equity0.46
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2021 Morningstar. All rights reserved.